Advertisement

Genentech Inc.: The South San Francisco-based biotechnology...

Share
From Times Staff and Wire Reports

Genentech Inc.: The South San Francisco-based biotechnology firm said its first-quarter profit surged 46% to $19.4 million on revenue that jumped 10% to $132 million. The company said a 26% surge in sales of its Protropin growth hormone helped boost results.

Advertisement